Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Effectiveness of Patient-centered Community Health Worker Support to Help Patients Control Chronic Disease [NA]
A clinical trial evaluated the effectiveness of patient-centered community health worker support to help patients manage chronic diseases, i…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: The Role of Acupuncture for the Treatment of Obstructive Sleep Apnea in Patients With Hypertension [NA]
This document reports the completion of a clinical trial evaluating acupuncture as a treatment for obstructive sleep apnea in patients with …
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Fresh Start Experiment [NA]
A clinical trial update indicates that the University of Pennsylvania–sponsored study NCT02411032 has completed. The study addressed diabete…
-
FDA approval · 2017-05-03FDA Approved: TELMISARTAN — Original Application (Solco Healthcare US, LLC)
The FDA approved Solco Healthcare US, LLC's original application for telmisartan, enabling a generic version of the blood pressure medicatio…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk [NA]
This record notes a completed human intervention trial sponsored by University College Cork evaluating an egg protein derivative for cardiov…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Optimal Remifentanil Ce for Preventing Severe Cough and Hyperdynamic Response During Tracheal Extubation [Phase 4]
This Phase 4 clinical trial update reports completion of a study evaluating remifentanil for preventing severe cough and hyperdynamic respon…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1) [Phase 1]
Phase 1 trial evaluating the effect of MK-8457 on blood pressure in participants with hypertension; results have been posted after completio…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney Disease
The clinical trial investigating renal denervation for resistant hypertension in patients with chronic kidney disease is no longer available…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction
This document notes the completion of a clinical trial in patients with hypertension and left ventricular dysfunction, sponsored by Elpen Ph…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension [Phase 2]
A Phase 2 clinical trial evaluated whether liquid potassium magnesium citrate can control blood pressure in hypertension. The study is compl…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients [NA]
Completed clinical trial evaluating the effects of fimasartan on insulin secretion in patients with type 2 diabetes mellitus and hypertensio…
-
CLINICAL_TRIALS research · 2017-04-28Clinical Trial Update: Integration of Guidelines for Comorbidities [NA]
This clinical trial update from Rambam Health Care Campus outlines a study focused on integrating guidelines for common comorbidities—type 2…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension [NA]
This update reports the completed status of the SYMPLICITY HTN-3 trial evaluating renal denervation in patients with hypertension. No effica…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4 [NA]
Clinical trial update indicating the SYMPLICITY HTN-4 study evaluating renal denervation for uncontrolled hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67) [NA]
A completed clinical trial evaluating the health effects of a low-salt bread on hypertensive subjects (ProAliFun67).
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Effect of Aerobic EXercise on MiCroVAscular RarefacTION in Chinese Mild HyperteNsive Patients（EXCAVATION-CHN1） [Phase 3]
A Phase 3 clinical trial update (EXCAVATION-CHN1) evaluating whether aerobic exercise impacts microvascular rarefaction in Chinese patients …
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Continuous Monitoring on the General Ward [NA]
This is a completed clinical trial update from Radboud University Medical Center about continuous monitoring on the general ward. It lists p…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare's generic olmesartan medoxomil tablets through an original ANDA for the treatment of hypertension.
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide from Aurobindo Pharma Limited under an Original Ap…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved an original abbreviated new drug application (ANDA) for olmesartan medoxomil, with Quallent Pharmaceuticals Health LLC as t…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for olmesartan medoxomil as a generic treatment for hypertension.
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Ascend Laboratories, LLC)
FDA approved olmesartan medoxomil as a generic antihypertensive drug for hypertension under an Original Application to Ascend Laboratories, …
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide from Alembic Pharmaceuticals Inc.
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for generic olmesartan medoxomil tablets from Jubilant Cadista Pharmaceuticals Inc. to treat hypertens…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for olmesartan medoxomil, a generic antihypertensive medication.